Skip to main content
    P

    Pelthos Therapeutics Inc. (PTHS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $6.89
    -0.26 (-3.64%)

    Market Cap: $28.10M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Pelthos Therapeutics Inc. (PTHS) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Pelthos Therapeutics (PTHS) has a latest price of $6.89 on Nov 17, 2026. Its price fell 79.5% over the past 12 months.

    Price Chart

    From Feb 2024 to Oct 2026, its highest month-end close was $37.70 in Feb 2024 and its lowest $6.11 in Nov 2024, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart PTHS with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PTHS.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 73.3%, and over 6 months it fell 74.5%.

    PeriodChange
    1 month-66.0%
    3 months-73.3%
    6 months-74.5%
    12 months-79.5%
    12 months, with dividends-79.5%
    Price change over each period. Dividends are not included unless the row says so.

    Price by Year

    YearCloseChange
    2026 through Oct 2026$9.40-69.7%
    2025$31.00+383.6%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 60.5% below its 50-day average of $17.46 and 70.4% below its 200-day average of $23.26.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$6.89
    50-day average$17.46-60.5%
    200-day average$23.26-70.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 88.7%.

    MeasureValue
    1-year beta1.01
    Largest fall, 1 year-79.3%
    Largest fall, 3 years-88.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About PTHS

    What is PTHS's 1-year price change?

    Pelthos Therapeutics's price fell 79.5% over the past 12 months. With dividends included, the 12-month total return was -79.5%.

    What is PTHS's beta?

    Pelthos Therapeutics's 1-year beta against the S&P 500 is 1.01, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 79.3%.

    Is the PTHS chart free?

    Yes. Advanced Charting for PTHS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.